Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2003

01-10-2003 | Letter to the Editor

Intensified Conditioning Regimen Has Only Limited Value for Patients with Progressive Multiple Myeloma

Authors: Naoki Takezako, Akiyoshi Miwa, Akira Tanimura, Chiho Inokuchi, Tateki Shikai, Noboru Yamagata, Atsushi Togawa

Published in: International Journal of Hematology | Issue 3/2003

Login to get access
Metadata
Title
Intensified Conditioning Regimen Has Only Limited Value for Patients with Progressive Multiple Myeloma
Authors
Naoki Takezako
Akiyoshi Miwa
Akira Tanimura
Chiho Inokuchi
Tateki Shikai
Noboru Yamagata
Atsushi Togawa
Publication date
01-10-2003
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2003
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02983808

Other articles of this Issue 3/2003

International Journal of Hematology 3/2003 Go to the issue

Letter to the Editor

Hyperthermia-Induced Pseudopodia (Thermopodia) Are Observed in Neutrophils from Febrile Patients

OriginalPaper

N-(4-Hydroxyphenyl)retinamide (4-HPR) Induces Leukemia Cell Death via Generation of Reactive Oxygen Species

OriginalPaper

Effects of the Tyrosine Kinase Inhibitor Imatinib Mesylate on a Bcr-Abl-Positive Cell Line: Suppression of Autonomous Cell Growth but No Effect on Decreased Adhesive Property and Morphological Changes

OriginalPaper

Radiation Protective Effect of an Extract fromChelidonium majus

OriginalPaper

Immunoregulatory Cells for Transplantation Tolerance and Graft-versus-Leukemia Effect

Case Report

Deficiency of Factor XIII Gene in Chinese: 3 Novel Mutations
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits